Here we have investigated expression of ILK in tumors and adjacent non-tumor tissues and correlated ILK expression with several TME factors in solid tumors, particularly in CRC where response to immunotherapy is unresolved (37). This evidence concerns the gene ILK and colorectal carcinoma.